Secondary Hemophagocytic Syndrome in a Patient with Plasma Cell Myeloma and CNS Involvement Treated with Lenalidomide

Secondary Hemophagocytic Syndrome in a Patient with Plasma Cell Myeloma and CNS Involvement Treated with Lenalidomide

We present an extremely rare case report of a 29-year-old multiple myeloma patient with central nervous system involvement and secondary hemophagocytic lymphohistiocytosis (HLH). We observed that HLH was presumably triggered by the immunomodulatory drug—lenalidomide. HLH is frequently misdiagnosed o...

Full description

Bibliographic Details
Main Authors: Sławomir Milczarek, Piotr Kulig, Bartłomiej Baumert, Aleksandra Łanocha, Krzysztof Sommerfeld, Ewa Borowiecka, Bogumiła Osękowska, Edyta Paczkowska, Barbara Zdziarska, Bogusław Machaliński
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Medicina
Subjects:
multiple myeloma
hemophagocytic lymphohistiocytosis
bone marrow transplantation
chemotherapy
Online Access:https://www.mdpi.com/1648-9144/58/10/1350

Internet

https://www.mdpi.com/1648-9144/58/10/1350

Similar Items